Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Nature Communications
|
May 11, 2021
LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells
María Ángeles Marqués-Torrejón, Charles A C Williams, Benjamin Southgate, et al.
CBE Life Sciences Education
|
April 11, 2025
Impacts of Learning Assistants on Student Belonging and Confidence Vary Across Science Disciplines and Course Contexts
Katherine A Clements, Kyle T Vallone, Thomas P Clements, et al.
Developmental Cell
|
April 21, 2023
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells
Valeria Amodeo, Timothy Davies, Amalia Martinez-Segura, et al.
Cell Reports
|
January 14, 2026
Microenvironmental TGF-β is an early driver of NF1-associated tumor formation
Alex Power, Salome Stierli, Elizabeth Harford-Wright, et al.
Nature Communications
|
April 15, 2022
Author Correction: The white matter is a pro-differentiative niche for glioblastoma
Lucy J Brooks, Melanie P Clements, Jemima J Burden, et al.
The American Journal of Cardiology
|
August 29, 2001
An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)
J M Rusnak, S L Kopecky, I P Clements, et al.
Nature Communications
|
April 13, 2021
The white matter is a pro-differentiative niche for glioblastoma
Lucy J Brooks, Melanie P Clements, Jemima J Burden, et al.
Elife
|
June 29, 2016
EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
Benjamin Krusche, Cristina Ottone, Melanie P Clements, et al.
Cell Reports
|
May 7, 2023
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin
Claudia Garcia-Diaz, Anni Pöysti, Elisabetta Mereu, et al.
The New England Journal of Medicine
|
July 8, 1982
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
J H Chesebro, I P Clements, V Fuster, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Nature Communications
|
May 11, 2021
LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells
María Ángeles Marqués-Torrejón, Charles A C Williams, Benjamin Southgate, et al.
CBE Life Sciences Education
|
April 11, 2025
Impacts of Learning Assistants on Student Belonging and Confidence Vary Across Science Disciplines and Course Contexts
Katherine A Clements, Kyle T Vallone, Thomas P Clements, et al.
Developmental Cell
|
April 21, 2023
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells
Valeria Amodeo, Timothy Davies, Amalia Martinez-Segura, et al.
Cell Reports
|
January 14, 2026
Microenvironmental TGF-β is an early driver of NF1-associated tumor formation
Alex Power, Salome Stierli, Elizabeth Harford-Wright, et al.
Nature Communications
|
April 15, 2022
Author Correction: The white matter is a pro-differentiative niche for glioblastoma
Lucy J Brooks, Melanie P Clements, Jemima J Burden, et al.
The American Journal of Cardiology
|
August 29, 2001
An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)
J M Rusnak, S L Kopecky, I P Clements, et al.
Nature Communications
|
April 13, 2021
The white matter is a pro-differentiative niche for glioblastoma
Lucy J Brooks, Melanie P Clements, Jemima J Burden, et al.
Elife
|
June 29, 2016
EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
Benjamin Krusche, Cristina Ottone, Melanie P Clements, et al.
Cell Reports
|
May 7, 2023
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin
Claudia Garcia-Diaz, Anni Pöysti, Elisabetta Mereu, et al.
The New England Journal of Medicine
|
July 8, 1982
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
J H Chesebro, I P Clements, V Fuster, et al.
Page
of 18